Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide

Dual bronchodilation with long-acting beta-2 agonists and muscarinic antagonists is recommended in patients with severe to very severe COPD. Among dual bronchodilator combinations, indacaterol/glycopyrronium combination (IGC) received evidence of higher efficacy and good safety compared with monothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridolo, Erminia, Pellicelli, Irene, Gritti, Bruna, Incorvaia, Cristoforo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338236/
https://www.ncbi.nlm.nih.gov/pubmed/30679906
http://dx.doi.org/10.2147/PPA.S166704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338236/
https://www.ncbi.nlm.nih.gov/pubmed/30679906
http://dx.doi.org/10.2147/PPA.S166704

Ejemplares similares